Evodiamine derivatives improve cognitive abilities in APPswe/PS1ΔE9 transgenic mouse models of Alzheimer's disease
Abstract Background Alzheimer's disease (AD) is a complex neurodegenerative disease. Due to the complexity of its molecular pathogenesis and the interaction of the numerous factors involved, the etiology and pathogenesis of AD have not been fully elucidated. Therefore, effective treatment for A...
Main Authors: | Shuo Pang, Caixian Sun, Shan Gao, Yajun Yang, Xiandao Pan, Lianfeng Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-06-01
|
Series: | Animal Models and Experimental Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/ame2.12126 |
Similar Items
-
Antitumor activity of 2 new evodiamine derivatives against small-cell lung cancer cells in vitro
by: JIANG Xuejun, et al.
Published: (2019-05-01) -
Pharmacological Actions of Multi-Target-Directed Evodiamine
by: Zhanli Wang, et al.
Published: (2013-01-01) -
Pharmacological Basis for the Use of Evodiamine in Alzheimer’s Disease: Antioxidation and Antiapoptosis
by: Yongfeng Zhang, et al.
Published: (2018-05-01) -
Antiproliferative Effects of Alkaloid Evodiamine and Its Derivatives
by: Xu Hu, et al.
Published: (2018-10-01) -
Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I Activity
by: Jau-Lang Hwang, et al.
Published: (2009-03-01)